Excretion pharmacokinetic analysis

If the unbound drug concentrations in plasma are higher than their K values on the transporters, then transporter function may be significantly affected [106], Following a pharmacokinetic analysis of the effect of probenecid on the hepatobiliary excretion of methotrexate, it has been shown the extent of an in vivo drug-drug interaction can be quantitatively predicted from the kinetic parameters for transport across the sinusoidal and bile canalicular membranes determined in vitro [107]. 

Example of pharmacokinetic analysis af urinary excretion data... 

Calculation of ID using biological monitoring techniques requires the knowledge of the pharmacokinetics of the parent pesticide in laboratory animals. This will allow the use of the parent or its urine metabolite(s) to calculate the total amount of the parent that had been absorbed through the skin of the test subject. The amount of the residue in the urine should be corrected for any molecular weight differences between the parent and its urine metabolite(s) and also corrected for daily urine excretion volumes based on creatinine analysis of the urine samples. 

Therefore, the pharmacokinetic parameters, which can be derived from blood level measurements, are important aids to the interpretation of data from toxicological dose-response studies. The plasma level profile for a drug or other foreign compound is therefore a composite picture of the disposition of the compound, being the result of various dynamic processes. The processes of disposition can be considered in terms of "compartments." Thus, absorption of the foreign compound into the central compartment will be followed by distribution, possibly into one or more peripheral compartments, and removal from the central compartment by excretion and possibly metabolism (Fig. 3.23). A very simple situation might only consist of one, central compartment. Alternatively, there may be many compartments. For such multicompartmental analysis and more details of pharmacokinetics and toxicokinetics, see references in the section "Bibliography." The central compartment may be, but is not necessarily, identical with the blood. It is really the compartment with which the compound is in rapid equilibrium. The distribution to peripheral compartments is reversible, whereas the removal from the central compartment by metabolism and excretion is irreversible. 

The rate of absorption of 2,k,5-T into the body appeared to be slower after external exposure than after oral administration in humans. Pharmacokinetic modeling indicated 91% of the 2,h,5-T absorbed through the skin would be cleared within 1 week. Measurement of 2,k,5-T excreted in urine of spray crews demonstrated that the maximum absorbed dose is not likely to exceed 0.1 mg per kg of body weight per work day. Urinary excretion provided a more reliable measure of dose than analysis of patches worn by the workers. Exposure was highest in mixers who handled the spray concentrate and in sprayers using backpack equipment. 

Absorption of a drug into the theoretical central or main compartment may be followed by distribution into one or more peripheral compartments, or the drug may undergo excretion or metabolism from the central compartment. While compartmental analysis of drug distribution can be informative, it is beyond the scope of this book. For more details on the effect of multicompartmental distribution of a drug on pharmacokinetics, see references in the Bibliography. 

The pKa is an important physicochemical parameter. The analyte pKa values are especially important in regard to pharmacokinetics (ADME—absorption, distribution, metabolism, excretion) of xenobiotics since the pKa affects the apparent drug lipophilicity [59]. Potentiometric titrations and spectrophome-tric analysis can be used for pKa determination however, if the compound is not pure, is poorly soluble in water, and/or does not have a significant UV chromophore and is in limited quantity, its determination may prove to be challenging. 

As seen earlier, exposure conditions amenable to pharmacokinetic/toxicokinetic analysis are such that the rate of the biological processes (e.g., diffusion across membranes, biotransformation, excretion by glomerular filtration, etc.) is proportional to the concentration or amount of a xenobiotic in a given compartment such as blood. The rate is then said to be governed by first-order kinetics (see Figures 2 and 3). 

---